Medical/Pharmaceuticals
Saxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12-17 years
BAGSVÆRD, Denmark, March 26, 2021 /PRNewswire/ -- Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda® is expanded for the treatment of obesity in adolescents aged 12–17 years...
2021-03-26 21:31
4047
Kintor Pharmaceutical Limited Announces 2020 Business Progress and Annual Results
SUZHOU, China, March 26, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (stock code 9939.HK, "Kintor Pharmaceutical" or the "Company"), a clinical-stage biotechnology company developing small molecule and biological therapeutics, recently announced its business highlights and financial result...
2021-03-26 20:54
6945
InnoCare Releases 2020 Annual Results and Business Highlights
BEIJING, March 26, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2020 annual results which ended onDec. 31, 2020. Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said, "During 2020...
2021-03-26 19:39
6219
Artificial Joint Surgical Robot, CUVIS-joint developed by CUREXO Receives EEA CE Marking
* Expands partnership with European implant and medical enterprises * Pursues US FDA approval SEOUL, South Korea, March 26, 2021 /PRNewswire/ -- On the 25th, medical robot company CUREXO, Inc. (KOSDAQ: 060280) announced that the in-house developed artificial joint surgical robot CUVIS-joint re...
2021-03-26 17:00
3784
Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)
Initiating Phase 1b randomized clinical trial with initial results expected in late 2021 Potential for novel, preventive AT-100 to reduce incidence and severity of serious respiratory disease BPD, improving outcomes and survival in very preterm infants CINCINNATI, March 26, 2021 /PRNewswire/ --...
2021-03-26 16:00
3532
Ascentage Pharma Announces Publication of Preclinical Data in Nature Immunology Showing Enhanced T-Cell-Mediated Antitumor Immunity Induced by Its MDM2-p53 Inhibitor APG-115
SUZHOU, China and ROCKVILLE, Md., March 26, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the peer-reviewed publicati...
2021-03-26 08:38
3186
Antengene Announces Financial Results for Full Year 2020
SHANGHAI and HONG KONG, March 26, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" or "the company", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in h...
2021-03-26 08:00
4408
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion
WUHAN, China, March 26, 2021 /PRNewswire/ -- Chime Biologics, a China-based, world-class CDMO company, announced today that it has secured a total commitment ofUS$190 million investment from institutional investors, and over $100 million investment has already been closed today. This round of fin...
2021-03-26 08:00
5842
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round
CINCINNATI, March 26, 2021 /PRNewswire/ -- Amplicore Inc., an early-stage biopharmaceutical company currently developing locally delivered and minimally invasive therapeutic solutions for musculoskeletal diseases, has successfully closed its Series Seed round of funding at$4 million. Investments ...
2021-03-26 05:19
3594
Antengene Appoints Kevin Lynch as Chief Medical Officer
SHANGHAI, China and MELBOURNE, Australia, March 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in ...
2021-03-25 23:26
4500
Antengene Appoints Bo Shan as Chief Scientific Officer
SHANGHAI, March 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, announc...
2021-03-25 22:36
5907
CStone Pharmaceuticals Reports Financial Results and Business Highlights for Full-year 2020
SUZHOU, China, March 25, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and precision medicines, today reported financial results and business highlights for the f...
2021-03-25 22:03
5034
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine
Multi-year agreement to expand commercial footprint with world-leading genomics platform and develop R&D to unlock the potential of multimodal health data BOSTON, LAUSANNE, Switzerland and TOKYO, March 25, 2021 /PRNewswire/ -- SOPHiA GENETICS SA ("SOPHiA GENETICS"), pioneer in Data-Driven Medicin...
2021-03-25 21:00
5438
Össur Recognized by World Intellectual Property Organization (WIPO) as Leading Assistive Technology Development
REYKJAVIK, Iceland, March 25, 2021 /PRNewswire/ -- Össur (Nasdaq: OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, has been recognized by the World Intellectual Property Organization (WIPO) for its intellectual property le...
2021-03-25 20:55
2179
China Eastern Flies Vaccines to Dominican Republic
SHANGHAI, March 25, 2021 /PRNewswire/ -- A new batch of vaccines developed by
Chinese pharmaceutical companies Sinopharm and Sinovac was delivered onMarch 18
by China Eastern Airlines fromBeijing to the Dominican Republic, according to
theShanghai-based airline.
2021-03-25 19:22
2110
BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers
MUNICH, March 25, 2021 /PRNewswire/ -- IQM Quantum Computers
2021-03-25 18:29
3484
111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform
SHANGHAI, March 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jianming Pharmaceutical Group ("Jianming Pharmaceutical"), a p...
2021-03-25 17:00
2752
AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine
AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou,...
2021-03-25 17:00
3481
GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development
SINGAPORE, March 25, 2021 /PRNewswire/ -- A global leading biotech company GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) announced that the Company has entered into a strategic partnership with the Theragen Etex, a South Korea-based comprehensive pharmaceutical and biotechnology...
2021-03-25 16:35
4852
Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar
TAIPEI, March 24, 2021 /PRNewswire/ -- In a press conference today, EirGenix, Inc. (6589.TT) announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimilar, EG12014 (proposed trastuzumab biosimilar, also called EGI014), has met its primary endpoint. E...
2021-03-24 23:27
4796
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 315 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia
2026-01-20 17:49
5428
